Abstract
We aim to understand the value of pursuing NCCN compendia without a formal FDA approval for an orphan drug indication expansion to circumvent Inflation Reduction Act (IRA) drug negotiation.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
